Financial Outlook

OUTLOOK 2018

Lundbeck’s results in 2018 are expected to be driven by the continued strong growth of Abilify Maintena®, Brintellix®/ Trintellix®, Northera® and Rexulti® which should more than compensate the effect of additional generic erosion on older products, and also the potential introduction of generic clobazam towards the end of the year. We expect to realize growth in local currencies in all our three geographical regions, North America, International Markets and Europe.
 
In 2018, we expect total revenue to be DKK 17.2-18.0 billion and EBIT to be DKK 4.8-5.2 billion. Lundbeck’s main currency is the USD and guidance is based on a USD exchange rate at the level it was by the end of January 2018. As a consequence of the US tax reform, Lundbeck expects the reported tax rate in 2018 to be 26-28% compared to 38.7% in 2017. The financial guidance is summarized below:
 

FINANCIAL GUIDANCE 2018

DKK  2017 actual 2018 guidance
Revenue 17,234m 17.2-18.0bn
EBIT 4,408m 4.8-5.2bn
Tax rate 38.7% 26-28%

 



Disclaimer

Forward-looking statements are subject to risks, uncertainties and inaccurate assumptions. This may cause actual results to differ materially from expectations.Factors that may affect future results include interest rate and exchange rate fluctuations, delay or failure of development projects, production problems, unexpected contract breaches or terminations, government-mandated or market-driven price decreases for Lundbeck's products, introduction of competing products, Lundbeck's ability to successfully market both new and existing products, exposure to product liability and other lawsuits, changes in reimbursement rules and governmental laws and related interpretation thereof and unexpected growth in expenses. Pursuant to section 107a of the Danish Financial statements Act, listed companies are under an obligation to consider whether they wish to disclose whether material agreements will be affected in the event of a change of control of the company. For reasons of competition, Lundbeck does not wish to disclose this.

Financial results

Quarterly results

Lundbeck has published the Annual report 2017. To view the report please click below.p>

 

English

Cookie Policy
You have chosen to leave www.lundbeck.com. Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on www.lundbeck.com.